Back to Journals » International Journal of Women's Health » Volume 5

Screening for Chlamydia trachomatis infection among infertile women in Saudi Arabia

Authors Kamel RM

Received 12 April 2013

Accepted for publication 1 May 2013

Published 6 June 2013 Volume 2013:5 Pages 277—284


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Download Article [PDF] 

Remah M Kamel

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Jazan, Saudi Arabia

Background: Chlamydia trachomatis infection is a worldwide-distributed sexually transmitted infection that may lead to infertility.
Objectives: This study aims to report the prevalence of Chlamydia trachomatis infection among infertile women in Saudi Arabia.
Patients and methods: A community-based study carried out at the obstetrics and gynecology clinic at Jazan General Hospital, Saudi Arabia. The study group included 640 Saudi infertile women who were aged between 18 and 40 years and who attended the gynecology clinic for infertility examination throughout 1 year of study (from July 1, 2011 to June 30, 2012). The randomized control group included 100 Saudi fertile women who attended the obstetrics clinic for routine antenatal care. All recruited women were screened for chlamydia infection by enzyme-linked immunosorbent assay (ELISA) for detection of serum-specific antibodies and then retested by the McCoy cell culture technique.
Results: The prevalence of Chlamydia trachomatis infection among infertile women was high, at 15.0%. The rate of chlamydia infection detected by ELISA was 9.84%, and it was 12.03% by the culture method (P = 0.2443).
Conclusion: The high prevalence of Chlamydia trachomatis infection among Saudi infertile women demands a national screening program for early detection among infertile couples. ELISA is available as a simple screening test alternative to the culture method.

Keywords: Chlamydia trachomatis, ELISA, McCoy cell culture, infertility, sexually transmitted infection

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]